SpringWorks Therapeutics Inc Capital Reinvestment Ratio
SpringWorks Therapeutics Inc capital reinvestment ratio. SpringWorks Therapeutics Inc (SWTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($15.07 Million) in capital expenditures ($54.00K). Check cash flow reinvestment rate of SpringWorks Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of SpringWorks Therapeutics Inc (2004–2010)
Capital reinvestment ratio of SpringWorks Therapeutics Inc from 2004 to 2010. This chart tracks SpringWorks Therapeutics Inc's Capital Reinvestment Ratio across 7 annual periods. Also explore SWTX shareholders equity momentum to track the company's year-over-year net asset growth rate.
SpringWorks Therapeutics Inc Capital Reinvestment Ratio by Year (2004–2010)
SpringWorks Therapeutics Inc capital reinvestment ratio by year from 2004 to 2010. For the full cash flow conversion analysis, see SpringWorks Therapeutics Inc (SWTX) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.34x | $5.61 Million | $1.89 Million | ▲ +2.1% |
| 2009 | 0.33x | $5.23 Million | $1.73 Million | ▲ +274.2% |
| 2008 | 0.09x | $7.10 Million | $626.00K | ▼ -29.3% |
| 2007 | 0.12x | $5.70 Million | $710.00K | ▼ -92.2% |
| 2006 | 1.59x | $748.00K | $1.19 Million | ▲ +733.4% |
| 2005 | 0.19x | $4.01 Million | $766.00K | ▲ +91.7% |
| 2004 | 0.10x | $3.83 Million | $382.00K | — |